SogoTrade Research Center








For Company Research, enter symbol or keyword and choose type of research:    Symbol Search
Alnylam Pharmaceuticals
(NASDAQ: ALNY) Add to Portfolio
$133.12
+4.12 (+3.19%)
as of Feb 20, 2020

Last 133.12
Change +4.12 (+3.19%)
Open 129.19
Prev. Close 129.00
Today's Range
128.00 133.61
52wk Range
65.81 134.51
Volume 714,900
Avg Volume 719,925
Sector SIC-2834 Pharmaceutical Preparations

Recent Headlines
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the 9th Annual SVB Leerink Global Healthcare Conference on Thursday, February (full story)
ALNY: 133.12 (+4.12)
Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $126.27 to a high of $130.03. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $127.41 on volume of 298,00 (full story)
ALNY: 133.12 (+4.12)
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that it has achieved full enrollment in its HELIOS-A Phase 3 study of vutrisiran, an investigational RNAi therapeutic in developm (full story)
ALNY: 133.12 (+4.12)
InvestorsObserver issues critical PriceWatch Alerts for ALNY, BBBY, MSFT, NVDA, and S. (full story)
ALNY: 133.12 (+4.12), BBBY: 12.67 (+0.06), MSFT: 184.42 (-2.86), NVDA: 308.70 (-6.00), S: 9.48 (-0.01)
Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $120.26 to a high of $128.21. Yesterday, the shares gained 3.9%, which took the trading range above the 3-day high of $125.73 on volume of 368 (full story)
ALNY: 133.12 (+4.12)
 
Performance Comparison
Name Today 3-Month 1-Year
ALNY +3.19% +7.56% +71.22%
Growth Rates
YTD +15.59%
1-Year +70.27%
3-Year +185.54%
5-Year +31.11%
10-Year +664.18%
© 2020 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. SEC Filings provided by Edgar Online. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.